APRI Quote Trading Chart Apricus Biosciences Inc.

$ Last:

-2.87% Change Percent:

$0.23 Open:

$0.22 Previous Close:

$0.23 High:

$0.2069 Low:

1,101,864 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2019-01-23	0.23	0.22	0.23	0.2069	1,101,864
2019-01-22	0.2397	0.2222	0.2397	0.213	1,289,707
2019-01-21	0.267	0.2381	0.267	0.2311	698,197
2019-01-18	0.267	0.2381	0.267	0.2311	690,440
2019-01-17	0.263	0.26	0.275	0.25	452,786
2019-01-16	0.2666	0.264	0.27	0.25	323,804
2019-01-15	0.28	0.27	0.28	0.2519	623,097
2019-01-14	0.27	0.2609	0.2731	0.2506	311,797
2019-01-11	0.231	0.27	0.2748	0.225	571,221
2019-01-10	0.24	0.2359	0.25	0.23	196,162
2019-01-09	0.2488	0.242	0.26	0.2301	415,418
2019-01-08	0.2609	0.237	0.2698	0.237	507,682
2019-01-07	0.25	0.2604	0.28	0.24	677,546
2019-01-04	0.2395	0.235	0.252	0.22	648,053
2019-01-03	0.24	0.226338	0.249	0.2174	646,953
2019-01-02	0.205	0.241	0.25	0.1851	1,174,124
2019-01-01	0.21	0.192	0.21	0.1851	463,205
2018-12-31	0.21	0.195	0.21	0.1851	436,764
2018-12-28	0.19	0.195	0.208	0.185	352,967
2018-12-27	0.2087	0.19	0.2087	0.1831	247,309

Stock Information

Apricus Biosciences Inc. Company Name:

APRI Stock Symbol:

NASDAQ Market:

Apricus Biosciences Inc. Website:

APRI Quote Trading Chart Apricus Biosciences Inc.

Get APRI Alerts

News, Short Squeeze, Breakout and More Instantly...

APRI - Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018

Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
APRI - Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results

Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...